Skip to main content

Table 3 Distribution of histological groups and selected histologies, year of diagnosis 2013

From: Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

Diagnostic group Men Women Sex ratio (M/F)
Cases Incidence rate per 100,000 per year Age at diagnosis (Median) Cases Incidence rate per 100,000 per year Age at diagnosis (Median)  
N % Crude Age-standa N % Crude Age-standa  
Sarcoma, NOS 645 18.9 1.9 1.3 71.4 470 13.7 1.3 0.8 71.5 1.4: 1
 Sarcoma, NOS 317 9.3 0.9 0.6 71.9 290 8.4 0.8 0.5 71.5 1.1: 1
 Spindle cell sarcoma 72 2.1 0.2 0.1 73.5 53 1.5 0.1 0.1 73.4 1.4: 1
 Giant cell sarcoma 170 5.0 0.5 0.3 72.9 87 2.5 0.2 0.1 72.5 2: 1
 Small cell sarcoma 7 0.2 0.0 0.0 41.8 3 0.1 0.0 0.0 46.2 2.3: 1
 Undifferentiated sarcoma 42 1.2 0.1 0.1 64.4 21 0.6 0.1 0.0 64.0 2: 1
Fibrosarcoma 475 14.0 1.4 1.0 71.0 305 8.9 0.9 0.6 61.5 1.6: 1
 Fibrosarcoma, NOS 48 1.4 0.1 0.1 64.0 36 1.0 0.1 0.1 67.3 1.3: 1
 Fibromyxosarcoma 82 2.4 0.2 0.2 70.3 59 1.7 0.2 0.1 68.3 1.4: 1
 Malignant fibrous histiocytoma 198 5.8 0.6 0.3 77.0 77 2.2 0.2 0.1 74.3 2.6: 1
 Dermatofibrosarcoma, NOS 93 2.7 0.3 0.2 50.2 95 2.8 0.3 0.2 45.8 1: 1
Liposarcoma 393 11.5 1.1 0.8 65.9 250 7.3 0.7 0.5 65.3 1.6: 1
 Liposarcoma, NOS 144 4.2 0.4 0.3 70.2 111 3.2 0.3 0.2 68.5 1.3: 1
 Liposarcoma, well differentiated 56 1.6 0.2 0.1 63.5 37 1.1 0.1 0.1 62.2 1.5: 1
 Myxoid liposarcoma 69 2.0 0.2 0.2 56.5 41 1.2 0.1 0.1 52.8 1.7: 1
 Dedifferentiated liposarcoma 89 2.6 0.3 0.2 70.8 32 0.9 0.1 0.1 69.6 2.8: 1
Uterine leiomyosarcoma 0 0.0 0.0 0.0 . 109 3.2 0.3 0.2 60.4
Non-uterine leiomyosarcoma 277 8.1 0.8 0.6 70.5 330 9.6 0.9 0.6 67.3 1: 1.2
Rhabdomyosarcoma 78 2.3 0.2 0.3 25.2 47 1.4 0.1 0.1 48.7 1.7: 1
 Rhabdomyosarcoma, NOS 19 0.6 0.1 0.1 53.3 18 0.5 0.1 0.0 56.3 1.1: 1
 Embryonal rhabdomyosarcoma 20 0.6 0.1 0.1 14.2 9 0.3 0.0 0.0 12.4 2.2: 1
Complex Neoplasia 169 5.0 0.5 0.4 61.2 741 21.5 2.1 1.3 69.8 1: 4.4
 Endometrial stromal sarcoma, NOS 0 0.0 0.0 0.0 . 75 2.2 0.2 0.1 62.2
 Endometrial stromal sarcoma, low grade 0 0.0 0.0 0.0 . 36 1.0 0.1 0.1 53.3
 Adenosarcoma 0 0.0 0.0 0.0 . 28 0.8 0.1 0.1 61.1
 Mullerian mixed tumor 0 0.0 0.0 0.0 . 206 6.0 0.6 0.3 72.6
 Carcinosarcoma, NOS 37 1.1 0.1 0.1 71.5 260 7.6 0.7 0.4 73.0 1: 7
 Synovial sarcoma, NOS 32 0.9 0.1 0.1 56.2 28 0.8 0.1 0.1 49.5 1.1: 1
 Synovial sarcoma, spindle cell 20 0.6 0.1 0.1 40.4 13 0.4 0.0 0.0 52.0 1.5: 1
Phylloides tumour, malignant 0 0.0 0.0 0.0 . 56 1.6 0.2 0.1 56.2
Angiosarcoma 233 6.8 0.7 0.5 69.5 168 4.9 0.5 0.3 72.8 1.4: 1
 Haemangiosarcoma, NOS 118 3.5 0.3 0.2 72.5 122 3.5 0.3 0.2 74.7 1: 1
 Kaposi sarcoma 87 2.6 0.3 0.2 61.4 17 0.5 0.0 0.0 72.9 5.1: 1
Osteosarcoma 85 2.5 0.2 0.3 35.8 67 1.9 0.2 0.2 39.8 1.3: 1
 Osteosarcoma, NOS 69 2.0 0.2 0.2 42.0 49 1.4 0.1 0.1 45.3 1.4: 1
Chondrosarcoma 105 3.1 0.3 0.2 60.8 119 3.5 0.3 0.2 61.4 1: 1.1
 Chondrosarcoma, NOS 81 2.4 0.2 0.2 60.8 100 2.9 0.3 0.2 62.0 1: 1.2
Giant cell neoplasia 4 0.1 0.0 0.0 56.6 5 0.1 0.0 0.0 58.3 1: 1.3
Ewing family of tumours 107 3.1 0.3 0.4 24.7 70 2.0 0.2 0.2 25.1 1.5: 1
 Ewing sarcoma 93 2.7 0.3 0.3 23.7 56 1.6 0.2 0.2 23.7 1.7: 1
Malignant ameloblastoma 2 0.1 0.0 0.0 72.8 4 0.1 0.0 0.0 50.0 1: 2
Chordoma 34 1.0 0.1 0.1 63.6 30 0.9 0.1 0.1 58.0 1.1: 1
 Chordoma, NOS 30 0.9 0.1 0.1 64.5 27 0.8 0.1 0.1 58.0 1.1: 1
Nerve sheath tumours 63 1.9 0.2 0.2 57.7 52 1.5 0.1 0.1 55.6 1.2: 1
 Malignant peripheral nerve sheath tumour 56 1.6 0.2 0.1 57.6 43 1.2 0.1 0.1 56.0 1.3: 1
GIST 734 21.6 2.1 1.5 69.5 619 18.0 1.7 1.1 70.2 1.2: 1
  1. aage-standardized incidence rates per 100,000 (European standard 1976)
  2. Bold text: Main groups